The Episealer® implant highlighted in three scientific publications
Episurf Medical AB’s (NASDAQ: EPIS B) Episealer® knee implant has recently been discussed in three peer-reviewed scientific publications. All three publications; “Current surgical options for the treatment of symptomatic articular cartilage lesions of the knee” (Biant, L.C. et al., Orthopaedics and Trauma, 2019. 33(2): 127-132), “Focal knee resurfacing” (Nahas, S., et al., Orthopaedics and Trauma, 2019. 33(2): 133-139) and “What future in the treatment of osteochondral knee defects?” (D’Ambrosi, R., et al., Annals of Translational Medicine, 2018, 6, Suppl 2, S100) discuss various treatment